Study of Blood and Cheek Cell Samples From Patients With Glioma - Trial NCT01009307
Access comprehensive clinical trial information for NCT01009307 through Pure Global AI's free database. This phase not specified trial is sponsored by University of California, San Francisco and is currently Completed. The study focuses on Brain and Central Nervous System Tumors. Target enrollment is 1709 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of California, San Francisco
Timeline & Enrollment
N/A
Oct 01, 2001
N/A
Primary Outcome
Factors related to glioma survival
Summary
RATIONALE: Studying samples of blood and tissue from patients with cancer in the laboratory
 may help doctors learn more about changes that occur in DNA and identify biomarkers related
 to cancer. It may also help doctors predict how patients will respond to treatment.
 
 PURPOSE: This research study is looking at blood and cheek cell samples from patients with
 glioma.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT01009307
Non-Device Trial